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Endopeptidase-24.18 (EC 3.4.24.18, E-24.18) is an oligomeric Zn-ectoenxyme. The a and B subunits have been cloned from both rat and mouse 
kidneys. The primary structure of these subunits revealed that they both contain the consensus Zn binding site and that they are members of the 
astacin family. Analysis of the hydropathy plot also suggested that they are anchored by a C-terminal hydrophobic domain. In order to verify the 
mode of anchoring of the rat E-24.18 a subunit and to test the functionality of the astacin-like domain in the a subunit when expressed alone, COS-1 
cells were transfected with a cloned cDNA for rat cc subunit. Despite the presence of its putative transmembrane domain, the a subunit was not 
anchored in the plasma membrane but rather secreted as a dimer into the culture medium. When the enzymatic activity of the secreted recombinant 
protein was tested in the azocasein degradation assay, the cz subunit was found to be inactive. Activity could, however, be revealed after mild trypsin 
digestion. This activity was abolished by replacing the Glu-157 in the active site by Val. Taken together our results suggest hat the a subunit of 
Endopeptidase-24.18 contains a latent astacin-like Zn metallopeptidase activity which could be secreted as a soluble nzyme by kidney and intestine. 
Meprin; Astacin; Ectoenzyme; Zymogen 
1. INTRODUCTION 
Endopeptidase-24.18 (EC 3.4.24.18, meprin, Endo- 
peptidase-2, PABA-peptide hydrolase, E-24.18) is an 
oligomeric metallopeptidase present on the brush bor- 
der membranes of rodent kidney proximal tubules [l] 
and in human intestine [2,3]. This peptidase hydrolyses 
in vitro a variety of extended peptides [1,4,5], but its 
physiological function remains unknown. Although E- 
24.18 was predominantly identified as a membrane- 
bound ectoenzyme with a protease-sensitive stalk do- 
main, it has also been found as a soluble form that 
retains proteolytic activity in rodent urine [6]. 
E-24.18 is composed of two subunits (a and p) and 
displays a multimeric organization of disulphide-linked 
subunits. The rat kidney enzyme has a tetrameric struc- 
ture resulting from the non-covalent association of di- 
sulphide-linked a and/? subunits, (a& [7]. On the other 
hand, three covalent tetrameric forms have been re- 
ported for mouse kidney enzyme: a4, ad2 and /34 [8]. 
The homotetrameric form of j? subunit was shown to be 
the latent metallopeptidase meprin B [9]. 
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Recently, the primary structures of the a and /I sub- 
units of rat and mouse E-24.18 have been deduced from 
the cDNA clones [7,1%12]. Both subunits have a simi- 
lar organization and contain an astacin-like protease 
domain which is characterized by the HExxHxxGFxHE 
consensus Zn binding sequence [ 13,141. The rat E-24.18 
a subunit is originally synthesized as a preproenzyme of 
748 amino acids and the mature form starts at Asn6’, 
implying the cleavage of the pro-region upstream of the 
astacin domain [lo]. This protein contains two hydro- 
phobic segments located at the N-terminus and close to 
the C-terminus of the protein [lo], respectively. The 
N-terminal hydrophobic segment is most likely the sig- 
nal peptide whereas the 20-amino acid C-terminal hy- 
drophobic segment might anchor the protein into the 
plasma membrane. 
In this paper we examined the anchoring of the a 
subunit in the plasma membrane by expression of the 
recombinant enzyme in transfected COS-1 cells. This 
system was also used to directly test the functionality of 
the astacin-like domain in the catalytic activity of the 
enzyme. 
2. EXPERIMENTAL 
2.1. Plasmids construction 
The full-length cDNA coding for the a subunit of rat E-24.18 was 
subcloned into the eukaryotic expression vector pSVP4 [15] which 
contains the SV40 early promoter/enhancer region. This plasmid, 
designated pSVP4-a was used for expression of the wild-type a subunit 
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cDNA in COS-I cells. Conversion of the Glu15’ codon (GAG) to Val 
(GTG) was accomplished by oligonucleotide-directed mutagenesis 
using a Ml3 subclone previously described (clone 6.2) [lo], according 
to the method of Taylor et al. [16]. The presence of the mutation was 
confirmed by DNA sequencing [17]. The mutated cDNA was substi- 
tuted for the wild-type cDNA fragment into pSVP4-a vector. 
2.2. Production of antibody against MBP-a subunit fwion protein 
A bacterial fusion protein of the E-24.18 a subunit was generated 
by inserting in frame the EcoRI cDNA fragment of clone 6.2 into a 
pMAL-c vector (New England Biolabs Ltd., Canada) downstream 
from the maZE gene encoding maltose-binding protein (MBP). The 
expression plasmid, called pMAL-a, was used to transform competent 
HBlOl E. coli. The MBP-a subunit fusion protein was overexpressed 
and purified according to the manufacturer’s protocol (ProFusion Kit, 
New England Biolabs Ltd., Canada). A polyclonal antibody L5a was 
generated in a New Zealand white rabbit with MBP-a subunit fusion 
protein. 
2.3. Transjection of COS-I cells 
COS-1 cells [18] were transfected using the standard calcium-phos- 
phate coprecipitation procedure [19]. The day following transfection, 
the serum-containing medium was changed for synthetic medium [20]. 
Spent medium was recovered 16 hours later and concentrated 8-fold 
by ultrafiltration using Centricon PM30 membranes. Transfected cells 
were harvested by scraping with a rubber policeman in ice cold Tris- 
buffered saline (TBS) (3 ml/Petri dish), pelleted by centrifugation and 
lysed with 2% (w/v) N-octyl-p-o-glucopyranoside (octylglucoside) in 
TBS. 
2.4. Western blotting 
Proteins from solubilized cells or concentrated culture media were 
resolved on SDS-PAGE [21] and transferred to nitrocellulose mem- 
branes (Schleicher and Schuell, Keene, USA; pore size 0.45 pm) using 
previously published procedures [22]. After transfer, the membranes 
were preincubated in TTBS solution (0.2% Tween-20 in TBS) for 30 
min and a 1:300 dilution of the L5a antiserum in TTBS was then added 
and incubated for 30 min at room temperature. After 3 washes in 
TTBS, a 1:500 dilution in TTBS of a biotinylated second antibody 
directed against rabbit immunoglobulins was added and incubated in 
the same conditions. The complexes were visualized with a Vectastain 
ABC-Immunoperoxidase kit (Vector Laboratories, Burlingame, CA) 
according to the manufacturer’s instructions. Endoglycosidase diges- 
tions prior to immunoblotting were performed as described previously 
[23]. The relative amount of the different molecular species was eval- 
uated by densitometric scanning using ultroscan XL Enhanced Laser 
Densitometer (LKB Bromma). 
2.5. Immunofuorescence microscopy 
COS-1 cells, grown on plastic coverslips placed in tissue culture 
wells, were transfected with pSVP4-a vector as described above. Two 
days after transfection, immunofluorescent s aining was performed 
essentially as described [24] using a polyclonal antibody L5a and an 
FITC-conjugated goat anti-rabbit IgG (Dimension Laboratories Inc. 
Canada), except hat the non-specific binding sites were blocked with 
0,1% (w/v) bovine serum albumin PBS solution. 
2.6. Enzyme assay 
E-24.18 activity was measured using azocasein as substrate by mon- 
itoring at 340 nm the release of dye-containing peptides that were 
soluble in 4% (w/v) trichloroacetic acid (TCA). Reactions were per- 
formed in 0.15 M NaCU20 mM ethanolamine (pH 9.5) buffer [25]. 
Briefly, 35 ~1 of solubilized COS-1 cells or 60~1 of I-fold concentrated 
culture medium were incubated for 60 min at 37°C with or without 
1Opg trypsin in a final volume of 100~1. A mixture (100~1) ofdifferent 
protease inhibitors (1 PM captopril, 1 ,uM phosphoramidon, 10 PM 
bestatin, 10 &ml aprotinin and 20 PM leupeptin) was then added to 
the samples and incubated for 20 min in the same conditions. Finally, 
900 ~1 of solution containing 11 mg of azocasein was added. After 
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90 min of incubation at 37°C 250 ~1 aliquots were precipitated in 1 
ml TCA. The samples were centrifuged for 5 min and the absorbance 
of the supematant was determined at 340 nm. Specific activities are 
expressed as units/mg protein/mm, one unit corresponding to the 
degradation of 1.1 fig azocasein. Protein concentrations were esti- 
mated by the method of Bradford [26]. 
3. RESULTS 
3.1. Production and characterization ofa E-24.18 a sub- 
unit-specific antibody 
A rabbit was immunized with an E. coli-derived fu- 
sion protein containing a portion of E-24.18 a subunit 
(see Section 2). Specificity of the antibody, named L5a, 
was verified by immunoblotting using detergent solubil- 
ized rat kidney membrane proteins. As shown in Fig. 1 
lane 1, a single immunoreactive band with an apparent 
molecular weight (M,) of 82 kDa was detected. This is 
in agreement with the M, of the a subunit previously 
reported [7]. The antibody did not recognize the B sub- 
unit of rat E-24.18 (Milhiet et al., submitted). 
3.2. Expression of E-24.18 a subunit in COS-1 cells 
COS-1 cells were transfected with pSVP4-a plasmid 
and expression of the a subunit was monitored using 
SDS-PAGE and immunoblotting with the L5a polyclo- 
nal antibody. In the supernatant of octyl-glucoside sol- 
ubilised cell membranes (cell extracts), E-24.18 a sub- 
unit was present as two distinct species with apparent 
M, of 98,000 and 82,000 (Fig. 1, lane 4). The 82 kDa 
band represented only a small fraction of the cell-associ- 
ated a subunit. To our surprise, analysis of proteins 
secreted in the culture medium revealed significant 
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Fig. 1. Immunoblot analysis of rat E-24.18 a subunit expressed in 
COS-1 cells. Proteins corresponding to one-fifth of a Petri dish of 
transfected cells were either recovered by octylglucoside solubilization 
of the cell pellet (C) or by concentration of the culture medium (M). 
The samples were analyzed by SDS-PAGE on 7.5% gel followed by 
immunoblotting with antiserum L5a. Lane 1: rat kidney BBM prepa- 
ration (30 pug); lanes 2,3: mock-transfected cells; lanes 4,5: a-trans- 
fected cells. The position of apparent molecular mass of the prestained 
proteins (myosin, 215.5 kDa; phosphorylase B, 105.1 kDa; bovine 
serum albumine, 69.8 kDa; ovalbumin, 43.3 kDa) (all obtained from 
Gibco) is indicated at the left. 
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Fig. 2. Endoglycosidase treatment of the E-24.18 LZ subunit. Proteins 
samples were treated with either endo H or PNGase F as described 
in Section 2, before analysis by SDS-PAGE as described in the legend 
to Fig. 1. Panel A: proteins from cell extract (C) or concentrated 
culture medium (M) of transfected COS-1 cells. Panel B: rat kidney 
BBM preparations (30 pg). The samples were either untreated (-), 
digested with endo H (H) or PNGase F (F). Position of size markers 
are indicated on both sides in kDa. 
amounts of a subunit immunoreactive material which 
appeared as a broad band with M, between 90,000 and 
105,000 (Fig. 1, lane 5). These secreted molecules repre- 
sented about 5560% of the total amount of im- 
munoreactive material present in both cell extracts and 
spent culture medium. No staining was observed in the 
cell extracts or culture medium of mock-tranfected cells 
(Fig. 1, lanes 2 and 3, respectively). The different forms 
of the protein recovered in the cell extracts were next 
submitted to endoglycosidase digestions. The two forms 
of the cell-associated a subunit were sensitive to both 
endo H and PNGase F (Fig. 2A, lanes 2 and 3) which 
reduced their apparent it4, by about 12 kDa. This result 
is consistent with the presence of 6 iV-glycosylation sites 
predicted by the cDNA-derived sequence. In contrast, 
the ‘soluble forms’ of the a subunit were mostly resis- 
tant to endo H digestion (Fig. 2A, lane 5). Treatment 
with PNGase F converted the a subunit into four lower 
M, forms, from 83 to 67 kDa (Fig. 2A, lane 6). A similar 
pattern of sensitivity to glycosydases was observed with 
the BBM-derived a subunit (Fig. 2B, lanes 2 and 3). 
3.3. Cellular localization of E-24.18 a subunits 
The localization of the cell-associated E-24.18 a sub- 
unit in transfected cells was next studied by indirect 
immunofluorescence microscopy with the L5a polyclo- 
nal antibody. There was no staining at the cell surface 
of intact cells (Fig. 3B). However, when cells were per- 
meabilized with Triton X-100 before incubation with 
the antiserum, a diffuse cytoplasmic fluorescence was 
observed around the nucleus consistent with a RER 
labelling (Fig. 3D). No staining was observed in mock- 
transfected cells (not shown). Thus both the endo H 
sensitivity of the cell-associated a subunits (see Fig. 2A, 
lane 2) and their cellular localization suggest that the 
cell-associated a subunits are present in the RER and 
not at the cell surface. 
3.4. Oligomerization of E-24.18 a subunit 
The multimeric organization of E-24.18 is unique 
among endopeptidases. The fact that the mouse a sub- 
unit has been found as homotetramers and the high 
degree of identity between rat and mouse a subunits, 
prompted us to investigate whether the rat a subunit 
alone could spontaneously form dimers. Both the cell 
extract and culture media of COS-1 cells expressing the 
a subunit were analyzed under non-reducing conditions 
by SDS-PAGE and immunoblotting. Under those con- 
ditions, most of the a subunit immunoreactive material 
detected in cellular extracts migrated as triple band with 
a M, around 190,000 whereas the intensity of the bands 
corresponding to the two monomeric species (82 and 98 
kDa) (Fig. 4 lane 3) had greatly diminished. Thus these 
high molecular weight forms are thought to result from 
the various combinations of the two monomeric species 
(82/82, 82/98, 98/98 kDa). In the spent culture medium 
only two bands were detected with mobilities corre- 
sponding to the lower molecular weight species found 
in cell extracts. The it4, of these dimers were found to 
be slighly lower than that of the a@ dimer present in rat 
BBM (lane 1). In addition the monomeric forms repre- 
senting less than 10% of the secreted molecules were 
found (lane 5). In COS-1 cells, these rat E-24.18 a sub- 
units therefore appear to be mostly secreted as dimers. 
3.5. Enzymatic activity of E-24.18 a subunit 
The rat a and /3 subunits contain both an astacin-like 
protease domain. It is not known if the catalytic activity 
Fig. 3. Immunofluorescent s aining of COS-1 cells expressing E-24.18 
a subunit. Transfected COS-1 cells were grown on coverslips and 
processed for indirect immunofluorescence asdescribed in Section 2. 
Panel B: intact cells. Panel D: Triton X-100 permeabilized cells. Panels 
A and C show phase contrast images of the cells. Bar = 10 pm. 
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ing of the recombinant a subunit at the cell surface after 
transfection in COS-1 cells. Our results show that 55- 
60% of the total Q! subunit synthesized by COS-1 cells 
is recovered in the secretion medium as Endo H resis- 
tant glycoproteins whereas the rest of the molecules are 
not located at the cell surface but rather appear to be 
trapped in the rough endoplasmic reticulum as Endo H 
sensitive forms. This suggests that the material recov- 
ered in the secretion medium has been secreted through 
the exocytic pathway and does not result from leakage 
of damaged cells. Thus in COS-1 cells at least, the 01 
subunit does not appear to be a membrane-bound en- 
zyme of the cell surface. The solubilization mechanism 
of the a subunit molecule is unknown. Although we 
cannot rule out the possib~ty that the putative trans- 
membrane domain is not functional, the molecular 
weight (about 67,000) of the faster migrating band 
found after PNGase F digestion of the CI subunit se- 
creted by COS-1 cells (Fig. 2A lane 6) is significantly 
smaller than the M, predicted from the cDNA-derived 
sequence (77,873) suggesting a proteolytic cleavage of 
the protein. Although this might be a phenomenon re- 
stricted to the COS-1 cell system, several observations 
lead us to believe that the same mechanism occurs in 
epithelial cells of the kidney and intestine: (i) when ex- 
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Fig. 4. Oligomerization of a subunit in CO&l cells. Proteins were 
recovered from the cells (C) or culture media (M) as described in the 
legend of Fig. 1 and analyzed by SDS-PAGE on 5% gel in non- 
reducing conditions prior the imm~oblotting. Lane 1: rat kidney 
BBM preparation (30 lug); lane 2,4: mock-t~nsfe~ cells; lane 3,5: 
a-transfected cells. The solid triangles represent monomers and diiers 
of E-24.18 a subunit. Molecular weight standards in kDa are indicated 
at the left. 
depends on one or both subunits. We therefore assayed 
the proteolytic activity of the recombinant ~11 subunit 
using azocasein as substrate. Enzymatic activity was 
expressed as unitsJmg protein/mine When assayed di- 
rectly, no activity was detected in the cell extract or 
culture medium of transfected cells (Fig. 5A,B). How- 
ever, as mouse E-24.1 8 (meprin A) has been shown to 
be activated by trypsin treatment when azocasein and 
insulin B chain were used as substrates [28], we decided 
to preincubate our samples for 1 hour at 37°C with 10 
pug trypsin. After inhibition of trypsin by aprotinin, the 
samples were then tested for their azocasein degrada- 
tion activity. In these ex~~ental conditions, a signif- 
icant proteolytic activity was detected in the samples 
recovered from the transfected cells (Fig. 5A,B, hatched 
boxes), whereas no enzymatic activity was observed in 
control mock-transfected cells. It is noteworthy that 
cell-associated forms of the tl- subunit are active despite 
their lack of fully processed o~gosa~ha~des. To ensure 
that the proteoiytic activity observed was due to the 
astacin-like domain of the recombinant enzyme, we re- 
placed the catalytic glutamic acid- 157 found in the con- 
sensus sequence (HExxH) by a valine residue (mutant 
aE157V). Although the secretion level of the mutated 
enzyme was not affected by the mutation (data not 
shown), no significant activity was detected in the cellu- 
lar extract or concentrated medium of the aEl57V- 
transfected cells after the trypsin treatment, de- 
monstrating the functional implication of the astacin- 
like domain. 
4. DISCUSSION 
Molecular cloning of rat and mouse a subunit 
cDNAs predicts that in both species the a subunit is a 
memb~ne-bond protein anchored by its C-terminus 
[lO,l 1). We therefore decided first to verify the anchor- 
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Fig. 5. Enzymatic activity of transfected cells. Cell-associated (A) and 
soluble (B) proteins from transfected COS-1 cells were assayed for 
azocasein degradation with or without trypsin activation as described 
in Section 2. The results are the means of three separate xperiments 
carried out in duplicate. The standard error (S.E.) is indicated by error 
bars. (**P < 0.005, as compared to mock-transfected cells using the 
Student’s t-test). 
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unit has also been found to be secreted as a soluble 
protein (Corbeil et al., unpublished results); (ii) in the 
BBM of mouse or rat kidneys where it is expressed as 
a heterodimer in association with the /3 subunit, the 
molecular weight of the a subunit does not change after 
solubilization of the activity by papain treatment [7,8], 
suggesting anchoring of a truncated u subunit through 
disulphide bonding with thep subunit rather than by its 
own putative membrane-spaming domain; (iii) the mo- 
lecular weight of the deglycosylated a subunit obtained 
after solubilization of E-24.18 from rat kidney BBM is 
the same as that of the de~ycosylated protein secreted 
by COS-1 cells (Fig. 2B, lane 2) and very close to that 
reported for mouse and human a subunits [3,9]. Two 
potential dibasic cleavage sites were found in the car- 
boxy1 terminal region of the a subunit; one of them was 
perfectly conserved between the rat and mouse a sub- 
unit. The RPKR sequence (residues 653 to 656) corre- 
sponds to the consensus RXIURR motif involved in 
precursor cleavage catalysed by furin [29]. As furin has 
already been proposed to act in the RER-Golgi complex 
[30], intracellular cleavage of the C-terminal region by 
furin could explain the secretion of the a subunit. Con- 
ration of the potential furin cleavage site by site- 
directed mutagenesis i  now in progress in our labora- 
tory. Finally, the fact that the inactive mutant aEl57V 
is secreted with the same efficiency shows that the secre- 
tion mechanism does not implicate an autocatalytic 
process as reported for another cell-surface glycopro- 
tein [31]. 
Our results clearly show that the rat a subunit alone, 
like the mouse protein, was able to form disulphide- 
bound multimers. However, only the dimeric form a, 
was observed. This contrasts with the cr, structure re- 
ported in vivo for the mouse protein. This different 
behaviour is su~~sing given that all the cysteine resi- 
dues were perfectly conserved between the two species. 
In particular, both contain EGF-like domain that could 
potentially mediate protein-protein interactions [27]. 
However, no disulphide-linked tetramers were observed 
in vivo in the rat. Similarly, biogenesis of human E- 
24.18 is well documents and it has been shown that this 
protein forms only dimers [2]. From these data, it ap- 
pears that the covalent tetrameric forms of the a subunit 
of E-24.18 are specific for the mouse enzyme. Thus, it 
is possible that structural features specific to the mouse 
protein or some factors found only in mouse epithelial 
cells allowed tetramer formation in this species. These 
different oligomerization processes between rodent spe- 
cies may account for distinct enzymatic properties [I] 
and for the expression of the homotetramers at the 
plasma membrane of the mouse kidney. In the rat, a/,3 
dimers represent the E-24.18 membrane-bound forms 
found at the plasma membrane of the kidney cells [7]; 
cl* dimers could however constitute the E-24.18 activity 
secreted into rat urine. Consistent with this latter hy- 
pothesis, we have recently observed by immunoblotting 
the presence of the a subunit into the rat urine (Simon, 
V. and Corbeil, D., unpublished results). The physiolog- 
ical function of this enzyme is unknown but it was pos- 
tulated to be implicated in the processing of urinary 
peptides that in part determine urinary odors [6]. 
When the catalytic properties of the recombinant rat 
a subunit were investigated using azocasein as sub- 
strate, it was found that the cx; subunit is initially synthe- 
sized in COS-1 cells as a zymogen. There is evidence 
that activity of mouse meprin A towards small peptides 
does not require trypsin activation 1281. The activity of 
our r~omb~ant a subunit towards low molecular 
weight substrates is presently under investigation. The 
in vivo mechanism for the enzyme activation is not 
known. Sequence alignment of all members of the as- 
tacin family showed a basic residue (arginine or lysine) 
or a cluster of basic residues located at the junction 
between the pro-region and the astacin-like domain [3 11. 
Cleavage at this site would generate a protein with a 
NH,-terminal peptide sequence identical to that found 
by amino acid sequencing of the mature form of the a 
subunit [lo]. Therefore, it is reasonable to suggest that 
a trypsin-like processing enzyme may be involved in the 
activation of the enzyme. Taken together our results 
suggest he presence of two sets of proteolytie events 
occuring both at the N- and C-termini of the a subunit. 
Some of these processing steps might be cell-specific and 
account for part of the heterogeneity of the im- 
munoreactive material found in cell extract and medium 
of transfected cells. In addition some post-translational 
Go&i-associated modifications such as U-linked glyco- 
sylation and tyrosine sulfation might also occur on the 
01 subunit and contribute to its heterogeneity. Solving 
the exact nature of all the forms of a subunit will require 
further work using sequence specific antibodies com- 
bined with peptide mapping and microsequencing ex- 
periments. Finally, it is clear that the astacin-like do- 
main is directly involved in the enzymatic activity of the 
rat E-24.18 a subunit, since the substitution of the first 
glutamic acid (E-157) in the consensus Zn-binding site 
of the a&&n-like domain by a valine residue essentially 
abolished any azocasein-de~a~ng activity. 
In summary, our results show that the a subunit pro- 
tein is secreted as a soluble form despite the presence of 
a putative transmembrane domain in its primary struc- 
ture. Furthermore, our results provide conclusive evi- 
dence that the astacin-like domain is enzymatically ac- 
tive in the rat E-24.18 a subunit although the enzyme 
is initially synthetized as a zymogen. Further studies are 
in progress in our laboratory to establish more com- 
pletely the specificity of this enzyme. 
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